Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MeOhr Ventures is an early-stage venture capital firm located in Haifa, Israel. The firm specializes in the life sciences sector, with a strong emphasis on biotech, medtech, digital health, and healthcare IT. Although it is still in the process of establishing its online presence, MeOhr Ventures is committed to deploying capital into concentrated early-stage opportunities that address critical health challenges.
The firm operates with a high-conviction investment strategy, focusing on innovative solutions that can lead to significant advancements in healthcare. MeOhr Ventures aims to catalyze cures for high-mortality diseases, aligning its investment strategy with the pressing needs of the healthcare sector.
MeOhr Ventures concentrates its investments in the life sciences sector, specifically targeting early-stage companies that are developing innovative solutions in biotech, medtech, digital health, and healthcare IT. The firm seeks to build a concentrated portfolio of high-conviction investments that can drive advancements in healthcare.
While specific details regarding check sizes and geographic focus are not publicly available, MeOhr Ventures is open to engaging with startups at any stage of development. The firm emphasizes its commitment to supporting life-science researchers and medical professionals, aiming to address globally significant health challenges through its investments.
Currently, MeOhr Ventures has not publicly identified any specific portfolio companies. The firm appears to operate with a concentrated, low-profile portfolio approach, focusing on a select number of high-potential investments in the life sciences sector.
This strategy allows MeOhr Ventures to maintain a high level of engagement with its portfolio companies, although no notable exits or current investments have been disclosed. The firm’s emphasis on addressing high-mortality diseases suggests that any future investments will likely align with this critical focus area.
MeOhr Ventures has not publicly disclosed specific preferences for pitching or application processes. However, founders are encouraged to reach out directly to the firm to initiate discussions about potential investment opportunities.
What are MeOhr Ventures' investment criteria?
MeOhr Ventures focuses on early-stage investments in the life sciences sector, particularly in biotech, medtech, digital health, and healthcare IT. The firm seeks innovative solutions that address high-mortality diseases.
How can startups apply or pitch to MeOhr Ventures?
While specific application procedures are not disclosed, MeOhr Ventures is open to engaging with startups at any stage of development. Founders are encouraged to reach out directly to the firm for potential discussions.
What makes MeOhr Ventures different from other VC firms?
MeOhr Ventures emphasizes a concentrated portfolio strategy, focusing on high-conviction investments that target significant health challenges. This approach allows for deeper engagement with portfolio companies.
What is the geographic scope of MeOhr Ventures?
The firm is based in Haifa, Israel, and primarily focuses on the Israeli life sciences sector, although it may consider opportunities globally.
What is the fund size or check size range for MeOhr Ventures?
Details regarding the fund size or specific check sizes have not been publicly disclosed. However, the firm is known for its concentrated investment strategy.
What type of post-investment involvement does MeOhr Ventures have?
MeOhr Ventures aims to add value by supporting portfolio companies in their mission to develop groundbreaking solutions for high-mortality diseases, leveraging its expertise in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.